AbbVie Inc. 8-K

What Happened
AbbVie announced its financial results for the fourth quarter and full year ended December 31, 2025 in a press release dated February 4, 2026. The company furnished that press release as Exhibit 99.1 to an 8-K filed on February 4, 2026 (Item 2.02: Results of Operations and Financial Condition).

Key Details

• Press release date: February 4, 2026.
• Reporting period: fourth quarter and full year ended December 31, 2025.
• Form 8-K filed and press release furnished as Exhibit 99.1 (Item 9.01 references the exhibit).
• Item reported on the 8-K: 2.02 (results of operations and financial condition).

Why It Matters
Earnings press releases provide core information investors use to evaluate company performance—revenue, profit, and any management commentary or guidance. By furnishing the press release on Form 8-K, AbbVie is publicly disclosing its Q4 and full-year 2025 results so shareholders and the market can assess recent performance and react accordingly. Investors should review the Exhibit 99.1 press release for the specific financial figures and any accompanying management commentary or outlook.